Whiskey et al. discuss the reasons for the underuse of clozapine among Black individuals with treatment-resistant schizophrenia and propose changes to enhance clinicians’ confidence in prescribing it to this population.
- Eromona Whiskey
- Christian Bachmann
- Ebenezer Oloyede